These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 11035733)

  • 1. Human neutrophil-mediated nonoxidative antifungal activity against Cryptococcus neoformans.
    Mambula SS; Simons ER; Hastey R; Selsted ME; Levitz SM
    Infect Immun; 2000 Nov; 68(11):6257-64. PubMed ID: 11035733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Purification and antimicrobial activity of human neutrophil defensins].
    Qu X; Wang A
    Zhonghua Yi Xue Za Zhi; 1991 Nov; 71(11):616-9, 42. PubMed ID: 1666973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms by Which Interleukin-12 Corrects Defective NK Cell Anticryptococcal Activity in HIV-Infected Patients.
    Kyei SK; Ogbomo H; Li S; Timm-McCann M; Xiang RF; Huston SM; Ganguly A; Colarusso P; Gill MJ; Mody CH
    mBio; 2016 Aug; 7(4):. PubMed ID: 27555306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro candidastatic properties of the human neutrophil calprotectin complex.
    Murthy AR; Lehrer RI; Harwig SS; Miyasaki KT
    J Immunol; 1993 Dec; 151(11):6291-301. PubMed ID: 8245468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of endothelial cells on phagocyte-mediated anticryptococcal activity.
    Roseff SA; Levitz SM
    Infect Immun; 1993 Sep; 61(9):3818-24. PubMed ID: 8359903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte colony-stimulating factor administration to HIV-infected subjects augments reduced leukotriene synthesis and anticryptococcal activity in neutrophils.
    Coffey MJ; Phare SM; George S; Peters-Golden M; Kazanjian PH
    J Clin Invest; 1998 Aug; 102(4):663-70. PubMed ID: 9710433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative killing of Cryptococcus neoformans by human neutrophils. Evidence that fungal mannitol protects by scavenging reactive oxygen intermediates.
    Chaturvedi V; Wong B; Newman SL
    J Immunol; 1996 May; 156(10):3836-40. PubMed ID: 8621921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of a human serum protein that inhibits the growth of Cryptococcus neoformans.
    Duvvuru S; Brummer E; Morelli R; Stevens DA
    Mycopathologia; 1998-1999; 144(1):1-7. PubMed ID: 10422267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nature of the effector cells responsible for antibody-dependent cell-mediated killing of Cryptococcus neoformans.
    Diamond RD; Allison AC
    Infect Immun; 1976 Sep; 14(3):716-20. PubMed ID: 786891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the two varieties of Cryptococcus neoformans cells and culture filtrate antigens on neutrophil locomotion.
    Dong ZM; Murphy JW
    Infect Immun; 1995 Jul; 63(7):2632-44. PubMed ID: 7790079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic components of natural killer cells limit the growth of Cryptococcus neoformans.
    Hidore MR; Nabavi N; Reynolds CW; Henkart PA; Murphy JW
    J Leukoc Biol; 1990 Jul; 48(1):15-26. PubMed ID: 2193078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fungicidal components of mammalian granulocytes active against Cryptococcus neoformans.
    Lehrer RI; Ladra KM
    J Infect Dis; 1977 Jul; 136(1):96-9. PubMed ID: 328789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of impaired anticryptococcal activity of monocytes from donors infected with human immunodeficiency virus.
    Harrison TS; Levitz SM
    J Infect Dis; 1997 Aug; 176(2):537-40. PubMed ID: 9237727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of human neutrophil peptide 4, a novel member of the defensin family.
    Wilde CG; Griffith JE; Marra MN; Snable JL; Scott RW
    J Biol Chem; 1989 Jul; 264(19):11200-3. PubMed ID: 2500436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8 T cell-mediated killing of Cryptococcus neoformans requires granulysin and is dependent on CD4 T cells and IL-15.
    Ma LL; Spurrell JC; Wang JF; Neely GG; Epelman S; Krensky AM; Mody CH
    J Immunol; 2002 Nov; 169(10):5787-95. PubMed ID: 12421959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-dependent natural killer cell-mediated growth inhibition of Cryptococcus neoformans.
    Nabavi N; Murphy JW
    Infect Immun; 1986 Feb; 51(2):556-62. PubMed ID: 3510982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opsonic requirements for dendritic cell-mediated responses to Cryptococcus neoformans.
    Kelly RM; Chen J; Yauch LE; Levitz SM
    Infect Immun; 2005 Jan; 73(1):592-8. PubMed ID: 15618199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen.
    Dong ZM; Murphy JW
    Infect Immun; 1993 Dec; 61(12):5067-77. PubMed ID: 8225584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptococcus neoformans directly stimulates perforin production and rearms NK cells for enhanced anticryptococcal microbicidal activity.
    Marr KJ; Jones GJ; Zheng C; Huston SM; Timm-McCann M; Islam A; Berenger BM; Ma LL; Wiseman JC; Mody CH
    Infect Immun; 2009 Jun; 77(6):2436-46. PubMed ID: 19307209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defensin-rich dense granules of human neutrophils.
    Rice WG; Ganz T; Kinkade JM; Selsted ME; Lehrer RI; Parmley RT
    Blood; 1987 Sep; 70(3):757-65. PubMed ID: 3040155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.